Elmiron, a highly sulfated, semisynthetic pentose polysaccharid e with properties similar to heparin, is used for the treatment of interstitial cystitis. Thirteen-week gavage studies were conducted by administering the drug in deionized water to F344/N rats and B6C3F 1 mice once daily, 5 days per week for up to 13 consecutive weeks, at doses of 0, 63, 125, 250, 500, and 1,000 mg/kg body weight. No signi cant drug-related effects were observed in body weight, survival, clinical, and necropsy results. Signi cant organ weight increases were seen in the liver, lungs, and spleen of both species and the kidneys of rats, mainly in groups treated with 250 mg/kg/day and above. Hematological analysis indicated increases for both species in the white blood cell and lymphocyte counts. Sites of toxicity identi ed histopathologicall y were the rectum, liver, mesenteric and mandibular lymph nodes (both sexes), spleen (mice only), and lungs and kidneys (rats only). Lesions consisted mainly of in ltration into multiple tissues of vacuolated histiocytes, which, by histochemical investigation, indicated the presence of neutral and acidic mucins and lipidic material within the vacuoles. Transmission electron microscopy identi ed these vacuoles as lysosomal structures that exhibited a variety of contents. On the basis of our ndings, we propose that Elmiron was absorbed through the focally disrupted rectal mucosa, was deposited in the lamina propria, accumulated within macrophages , and then was distributed by these cells or as a free chemical via the lymphatics and blood, to the various organ sites manifesting histiocytic in ltration. The cytoplasmic membrane-boun d structures within macrophages were lysosomes containing membranou s material of cellular origin and, perhaps, remnants of the deposited test material, Elmiron.
INTRODUCTION
Elmiron (xylan hydrogen polysulfate, sodium pentosan polysulfate, Figure 1 ), manufactured from raw materials obtained from beechwood shavings (14) , is a drug similar to heparin (24) and exhibits antilipidemic and marked anticoagulant activities; brinolytic, anti ogistic, and mild antihypertensive effects; and inhibition of vascular smoothmuscle-cell proliferation (8) . It exerts signi cant anticoagulant activity in humans and animals by reducing thrombin production, impairing the generation of chromogenic antifactor Xa, and increasing levels of lipoprotein lipase and euglobin clot lysis (9) . Elmiron is marketed outside the United States for use as a heparin-like anticoagulant in doses from 50 to 100 mg sc. TID, and it produces not only the expected toxicity of bleeding complications but also, rarely, thrombocytopenia, elevated transaminases, and thromboembolic reactions (15) . In the United States, Elmiron is used for the compassionate treatment of interstitial cystitis under the Investigative New Drug (IND) procedure. The mode of action of Elmiron may be due to its ability to coat the urinary bladder wall, thus preventing the attachment of the pathogen responsible for this disease (7) .
No information is available in the literature regarding the acute, subchronic, or reproductive effects of Elmiron. Animal studies have been limited and directed more towards toxicokinetics and the evaluation of its pharmacological properties (1, 9) .
The purpose of this paper is to report the short-term toxicity of Elmiron and describe changes observed in rats and mice that are consistent with drug-induced lysosomal-storage disorder.
MATERIALS AND METHODS
Chemical: Elmiron (CAS No. 37319-17-8, approximately 96% pure) was supplied by Baker Norton Pharmaceuticals, Inc., Miami, Florida, with no detectable impurities greater than 0.1%.
Animals: Both sexes of F334/N rats and B6C3F 1 mice were obtained from Taconic (Germantown, NY) at 4 to 5 weeks of age. After quarantine for 11 to 12 days, rats and mice were randomly assigned to Elmiron-exposure or control groups and housed 5 per cage (except for the individually housed male mice) in polycarbonate cages. Pelleted food (NTP-2000, Zeigler Bros., Gardners, PA) and water were available ad libitum. The animals were observed twice daily and weighed weekly. Animal husbandry and handling were conducted in accordance with the NIH Guidelines (11) .
Doses and Study Design:
Solutions of Elmiron were formulated in deionized water for gavage administration at concentrations of 0, 63, 125, 250, 500, and 1,000 mg/kg; rats and mice were administered the same dosages. The animals were randomized to a core study group (10 animals/sex/group) or a special study group used for hematology and clinical 178 chemistry evaluation (20 animals/sex/group). Doses were delivered by gavage in dose volumes of 5 ml/kg of body weight and adjusted according to each animal's most recent weekly body weight. Doses were administered 5 times per week on weekdays for 13 consecutive weeks. For rats, blood samples were collected for activated-partial-thromboplastin time (APTT) determinations and hematology and clinicalchemistry parameters on days 4 and 23 and at termination (4) . For mice, blood samples were collected only for analysis of hematological parameters at termination of the study.
Necropsy and Tissue Handling: Rats and mice were sacri ced using 70% CO 2 anesthesia followed by exsanguination. A complete necropsy and microscopic examination were performed on all animals found moribund or dead and those sacri ced terminally. At scheduled sacri ce, weights of the liver, spleen, thymus, right kidney, heart, lungs, and right testis were recorded. Samples of all tissues including gross lesions were collected and xed in 10% neutral-buffered formalin. Tissues were processed, embedded in paraf n, sectioned at 5 to 6 l m, and stained with hematoxylin and eosin (H&E) for microscopic examination (4) . Selected target organs were stained by alcian blue pH 2.5 (AB), periodic acid Schiff (PAS), and oil-red-oil (ORO) using frozen tissue.
Electron Microscopic Examination: Small samples (1 mm 3 ) of formalin-xed lungs and mandibular and mesenteric lymph nodes from rats and mice and rectum from rats only were prepared for electron microscopy by immersion in a mixture of 1% glutaraldehyde and 4% commercial formalin (16) . The selected tissues were then processed into Spurr's resin for ultrastructural examination. Thick (1 l ) sections were cut, stained with toluidine blue, and examined to select representative areas for further electron microscopic processing. Thin sections (approximately 90 nm) were cut, mounted on 200-mesh copper grids, stained with 5% methanolic uranyl TABLE 1.-Summary of body weights (g), organ weights (g), and organ-to-body weight ratios a in F344 rats exposed to Elmiron by gavage for 90 days. acetate and Reynold's lead citrate, and examined in a Zeiss 900 transmission electron microscope. Electron micrographs of selected representative ultrastructural ndings were evaluated.
RESULTS

Survival, Body Weight, and Organ Weight
No drug-related mortality was observed. In rats (Table 1) , the absolute liver weights were statistically signi cantly elevated in males treated with 250 and 1,000 mg/kg Elmiron and in all dosed female groups. Relative liver weights were signi cantly increased in a dose-related manner in males treated with 250 or 1,000 mg/kg and in all treated female groups. Absolute and relative spleen weights were significantly increased for males treated with 125 mg/kg and for the high-dose (1,000 mg/kg) females. Absolute spleen weights were also signi cantly increased in the males treated with 63 mg/kg. The absolute lung weights of the females treated with 125 mg/kg and the absolute and relative lung weights in the high-dose (1,000 mg/kg) females were statistically signi cantly increased. Kidney absolute and relative weight values were statistically signi cantly increased relative to control for the female 1,000 mg/kg group.
In mice (Table 2) , the absolute and relative liver weights were signi cantly increased in males treated with 500 and 1,000 mg/kg of and in females treated with 250 or 1,000 mg/kg. The relative liver weights were also increased in females treated with 500 mg/kg. In male mice, absolute and relative splenic weights were signi cantly increased in the high-dose (1,000 mg/kg) group. Absolute splenic weights were elevated in high-dose female mice. The relative lung weights were increased in females treated with 125 and 1,000 mg/kg.
Clinical Pathology Findings (Tables 3 and 4)
Increased numbers of white blood cells (WBC) and lymphocytes were noted in both species and sexes treated with the higher doses of Elmiron (17) .
In rats, the WBC and lymphocyte values of the 1,000 mg/kg/day groups of both sexes were statistically different from controls at all time points. In the 500 mg/kg group, the same parameters for both sexes were statistically different from control at day 4 but manifested no statistically TABLE 2.-Summary of body weights (g), organ weights (g), and organ-to-bod y weight ratios a in B6C3F1 mice exposed to Elmiron by gavage for 90 days. signi cant differences at later time points. There was a slight increase in the APTT in the 500 and 1,000 mg/kg groups of both sexes. This speci c change is attributed to the known anticoagulant activity of Elmiron.
In mice, the WBC and lymphocyte counts were statistically increased in the 1,000 mg/kg group.
Histopathology
In both mice and rats, the treatment-related changes were relatively comparable (Tables 5-6 ). Histopathologic changes were dose-related, and target organs in both species were the rectum, liver, and mesenteric and mandibular lymph nodes. The spleen was affected only in mice; lungs and kidneys had changes only in rats.
Rectum: In both species in all treated males and females, treatment-related changes consisted of histiocytic in ltration, chronic active in ammation, and chronic ulcers. Ulcers were not seen in female mice. In rats, no rectal lesions were seen in the males treated with the 63 mg/kg, and, in mice, lesions did not appear in males treated with 63 and 125 mg/kg and females treated with 63, 125, and 250 mg/kg. Histiocytic in ltration was characterized by minimal to mild aggregations of foamy macrophages within the lamina propria, which lled and distended it resulting in disorganization and distortion of the mucosal crypts. Macrophages were large with abundant foamy cytoplasm due to the presence of numerous intracytoplasmic, variably-sized, clear vacuoles ( Figure 2 ). The lamina propria appeared expanded with a faint bluish-tinged extracellular material indicating a myxomatous change.
In rats, chronic active in ammation and ulcers were noted in both sexes treated with 500 and 1,000 mg/kg and in males treated with 250 mg/kg. In mice, chronic active in ammation was noted in both sexes treated with 1,000 mg/kg and in females treated with 500 mg/kg, while ulceration was seen only in males treated with 1,000 mg/kg. Chronic active in ammation was characterized by the presence of lymphocytes and neutrophils in the lamina propria, mucosa, and/or lumen of the rectum. Ulceration consisted of focal denudation of the epithelial lining ( Figure 3 ). These areas usually exhibited an in ammatory base. Some of these mucosal areas appeared to be healing from the previous ulceration characterized by attenuated epithelium covering the surface of the lamina propria associated with loss of mucosal crypts.
Mandibular and Mesenteric Lymph Nodes:
Histiocytic in ltration, consisting of large macrophages with foamy cytoplasm lled with variably-sized clear vacuoles, was noted in all rat male and female treated groups, except males treated with 63 and 125 mg/kg. In mice, the same changes were noted in all male and female treated groups, except females treated with 63 and 125 mg/kg. Macrophages were located in the subcapsular and/or medullary sinuses ( Figure 4 ).
Kidneys:
In rats, tubular epithelial vacuolation in the outer cortical, particularly subcapsular, region was observed in both sexes treated with 1,000 mg/kg and characterized by the presence of one to several small, clear, cytoplasmic vacuoles.
Lungs: In rats, focal or multifocal alveolar histiocytic in ltration was noted in both sexes of all groups and appeared more severe in the higher-dosed groups ( Figure 5 ). Chronic interstitial in ammation occurred in both sexes treated with 500 and 1,000 mg/kg and in females treated with 250 mg/kg. This change was characterized by brosis of the alveolar wall and in ltration of the interstitium with lymphocytes and macrophages.
Liver: In rats, midzonal hepatocytic cytoplasmic vacuolization was seen in both sexes treated with 1,000 mg/kg and in males treated with 500 mg/kg. The vacuoles were clear and variably sized-characteristics consistent with fatty change. In some animals the vacuolation consisted of clear cytoplasmic areas typical of glycogen in ltration. Multifocal granulomatous in ammation was seen in males treated with 500 and 1,000 mg/kg as aggregations of histiocytes mixed with mononuclear cells. In mice, centrilobular hepatocytic cytoplasmic vacuolation was noted in both sexes treated with 1,000 mg/kg and in males treated with 500 mg/kg. Vacuolization was characterized by the presence of clear, spherical vacuoles in the cytoplasm of hepatocytes-suggesting the presence of fat. The 1,000 mg/kg treated mice of both sexes had more severe in ammation, consisting of macrophages, monocytes, lymphocytes, and neutrophils scattered throughout the parenchyma, compared to the minimal background in ammation seen in the corresponding controls.
Spleen: In mice, histiocytic in ltration characterized by the presence of macrophages with cytoplasm lled with one to several clear vacuoles was noted in all male and female treated groups, except males and females treated with 63, 125, and 250 mg/kg and males treated with 500 mg/kg. The macrophages were located in the red pulp and mantle zone of the white pulp.
Histochemical Investigation
Samples of spleen, rectum, liver, and mesenteric and mandibular lymph nodes of rats and mice and rat lung from TABLE 6.-Incidence of selected treatment-related lesions in B6C3F1 mice exposed to Elmiron by gavage for 90 days (n 10). animals treated with 1,000 mg/kg, and the same number of samples from concurrent controls, were stained for the acidic sulfated mucopolysaccharides, hyaluronic acid, and sialomucin (AB); neutral mucopolysaccharides (PAS); and neutral lipids (ORO). In the mouse, occasional histiocytes containing PAS-positive cytoplasmic material were noted in the mesenteric lymph node and spleen. In the spleen only, these cells also contained AB-positive material. In rats, histiocytes containing PAS-positive material were noted in the lamina propria of the rectum, mesenteric and cervical lymph nodes, liver, and lungs. Only in the rectum and lungs, the accumulated material within the vacuolated cells was also AB-positive. Only in the lungs, the accumulated material within the vacuolated cells was ORO-positive. The grade of staining varied in intensity and was most prominent in lung and of minimal to mild intensity in the rectum, liver, and lymph nodes. The extracellular material accumulating in the lamina propria stained negatively with the PAS reaction but positively with an AB stain; these results indicated increased levels of proteoglycans.
Electron Microscopic Investigation
Rectum: Many macrophages were evident within the lamina propria of the rectum examined ultrastructurally Figure 6 ), and these displayed voluminous cytoplasm that was distended with numerous variably sized lysosomes. Some lysosomes were clear or had scant pro les of membranous material, but most were lled with concentric lamellae of electron-dense material. Other cells in the lamina propria were those normally present in this tissue and included eosinophils, occasional neutrophils, broblasts, and lymphoid cells. The interstitium contained multiple small bundles of collagen.
Lung: Unusual alveolar macrophages were identi ed ultrastructurally in both mice and rats, although, for mice, pulmonary histiocytic in ltrates were not a signi cant light microscopic nding. These alveolar macrophages exhibited unusual lysosomal changes (Figures 7-8 ). One mouse (Figure 7 ) displayed distinct linear crystalline inclusions within lysosomes of alveolar macrophages; these electron-dense structures were membrane-bound and single or multiple. Some macrophages contained more lysosomal crystals than others, and in some lysosomes deposited material other than the linear crystals was present. A few linear crystals within macrophagic lysosomes were also identi ed in 1 rat; some appeared to have a lucent core. Another rat lung (Figure 8 ) exhibited numerous large alveolar macrophages with cytoplasm distended by rounded lysosomes that appeared clear or contained electron-lucent material as well as concentric lamellar bodies and fragments of materials similar to those seen in the macrophages of the rectum.
Lymph Nodes: Vacuolated macrophages were evident in the subcapsular sinuses of the lymph nodes (Figures 9-11 ) and were interspersed with lymphocytes. Some macrophages were engorged with lysosomes containing concentric lamellar bodies similar to those seen in the rectum. Other macrophagic lysosomes were mostly clear and contained only fragments of concentric lamellar bodies. Additionally, many macrophages contained electron-dense residual bodies (Figure 11 ). Occasionally, lysosomes with linear crystalline inclusions were observed.
DISCUSSION
The multiple-organ accumulation of foamy macrophages is the main feature of Elmiron treatment in rats and mice. The histochemical investigation indicated that the vacuolated cells accumulated mucins, hexosamine-containing polysaccharides covalently bound to varying amounts of protein.
The positive staining for both neutral and acidic mucins in the same cells indicates that the vacuolated cells contained a mixture of different types of mucin. The positive reaction for ORO staining indicated the presence of a lipidic component in the vacuoles. Electron microscopic examination of the vacuolated cells revealed cytoplasmic membrane-bound structures, morphologically indicative of the diagnosis of lysosomalstorage disorder.
In inherited lysosomal-storage disease in humans, there is a de ciency in or malfunction of one of the enzymes participating in the breakdown of complex, large macromolecules (5) that may be derived from the metabolic turnover of intracellular organelles or acquired extracellularly. The lysosomes become suf ciently large and numerous to cause interference with normal cellular functions leading to the disorder (5) . Because cells of the mononuclear system possess numerous lysosomes, organs rich in phagocytic cells, such as the spleen and liver, are frequently enlarged in several forms of lysosomal-storage disorders. The chemical structure and amount of substrate found in a particular cell type determine the ultrastructural appearance of the lysosomal-storage disorder (3) . The enzymatic dysfunctions are divided into categories based upon the biochemical nature of the accumulated metabolite, such as glycogenoses, mucopolysaccharidoses, and mucolipidoses. According to Prasad et al (18) , the different morphological aspects observed in a particular lysosomal-storage disorder may vary in appearance, depending on the storing cell type, because some enzymes are involved in the catabolism of more than one substrate. For example, in a certain glycoproteinosis, one cell type may accumulate oligosaccharides, and another cell type will store glycolipids (18) .
The prominent lysosomal changes seen in rats and mice treated with Elmiron suggest a drug-induced storage disorder similar morphologically to those types reported in the literature (13, 21, 23) . For example, the cationic amphiphilic drug (CAD)s are known to induce phospholipidosi s in experimental animals. This group includes a wide variety of pharmacologic agents that are aromatic and are miscible with water and organic solvents and share a common physicochemical structure-the presence of a hydrophobic ring on the molecule and a hydrophilic side chain with a charged cationic amine group (12) . The Elmiron is a sulfated pentose sugar soluble in water.
The range of ultrastructural morphological features of CAD-induced phospholipidosi s includes the presence of electron-lucent vacuoles; concentric intravescicular lamellar bodies; clear cytoplasmic vacuoles with occulent, peripheral, electron-dense structures; and crystalline, electron-dense bodies (13, 23) . That the various morphological aspects induced by the CADs are bidirectional processes between states of liqui cation and coacervation, resulting in heterogenicity of the morphologic alterations, has been suggested (13) . As the vacuoles become progressively larger with time, they apparently accumulate electron-lucent material. Progressive vacuolar coalescence and accumulation of electron-lucent material result in cellular enlargement. The CAD disobutamide was found to induce lysosomalstorage disorder in the rat and dog in which smooth muscle cells, epithelial cells, macrophages, broblasts, capillary endothelium, cardiac myocytes, hepatocytes, and ocular uveal cells were involved in cytoplasmic vacuolation (23) . Various investigations have demonstrated that the primary site for the induction of drug-induced phospholipidosi s is the lysosomal fraction (13) . Another example of drug-induced lysosomal storage of crystalline structures was reported in rats treated with S-AB 1316 SE, an antithrombotic amphiphilic, but not cationic, drug (22) . The needle-shaped crystalline structures were found in the liver within Kupffer's cells and occasionally also in the hepatocytes.
Several mechanisms for drug-induced phospholipidosi s have been suggested (12) . One involves binding of the drug to phospholipid s and, as a consequence, the formation of a new substrate-the substrate-drug complex-that is less susceptible to phospholipases associated with decreased catabolism; thus, degradation is impaired. Another possibility is that the drug binds to enzymes resulting in reduced phospholipidic degradation. Alternatively, the drug may bind to the plasma membrane or intracellular membranes, such as acidic vesicles, mitochondria, endoplasmic reticulum, or nucleus, with subsequent aberration of membrane synthesis, recycling, turnover, or traf cking. The immunomodulator tilorone was found to impair the lysosomal catabolism of sulfated glycosaminoglycans (GACs), thereby inducing their generalized lysosomal storage. The drug molecule may form complexes with the GACs that render them resistant to the enzymatic degradation (2) . Another mechanism of druginduced storage disorder was demonstrated in the case of the trypanocidal drug suramin. This drug was found to be a potent inhibitor of lysosomal enzymes, such as iduronate sulfate, b -glucuronidase, and hyaluronidase, required for the degradation of GACs (19) .
The structure of Elmiron differs from that of CADs. In addition, only 1 type of cell-the macrophage-is involved in the Elmiron-induced storage disorder. Despite the uniqueness of Elmiron, however, the mechanism for the storage disorder is likely similar to that described for CADs (13) in which concentric lamellar bodies develop from hydration of lipidic material (10) . The cytoplasmic membrane-bound structures within macrophages are lysosomes containing membranous material of cellular origin and, perhaps, remnants of the deposited test material, Elmiron. Due to the histochemical positivity of the accumulating material for mucin and lipids, the disorder induced by Elmiron is suggested to be of the mucolipidosis type.
Limited published information is available on the absorption, distribution, metabolism, or elimination of Elmiron per se in animals. Distribution of tritiated Elmiron was studied in Sprague-Dawley rats receiving an oral dose of 5 mg/kg either orally or intravenously (7) . Autoradiography showed that the drug was distributed extensively in the whole animal, most notably in the connective tissue and, to a lesser extent, in the bone and cartilage. The most conspicuous observation was the high concentration of activity in the urine and the preferential localization of activity in the lining of the urinary tract (pelvis, ureter, and bladder). A comparative IV (50 mg) and oral (1,500 mg) bioavailability study of Elmiron using healthy young male volunteers was recently conducted (8) . In the absence of speci c assays to measure Elmiron in the blood, indirect methods (ie, measurement of prolongation of APTT and increases in anti-Xa and hepatic triglyceride lipase activities) were used. That IV administration of Elmiron changed the pharmacodynamic parameters in an expected way, comparable to other heparin-like compounds, was demonstrated. On the other hand, oral administration of Elmiron resulted in insigni cant effects, indicating low bioavailability even with a high oral dosage. That Elmiron is poorly absorbed after oral administration or extensive presystemic breakdown occurs was postulated. Danielson et al (6) demonstrated the poor oral absorption of Elmiron in healthy volunteers, comparing oral (400 mg) with IV (40 mg) bioavailability. Results indicated that the oral bioavailability was < 1% after a single dose.
In our studies, following Elmiron oral dosing, the greatest abundance of vacuolated histiocytes, within rectal tissue and mesenteric lymph nodes, suggested that the focally disrupted, rectal mucosal barrier served as the port of entry for Elmiron or its metabolites. The rectal lamina propria appeared expanded with a faint, bluish-tinged, acellular material indicative of a myxomatous change. This material stained positively with AB that highlights sulfated mucopolysaccaride-like compounds, such as normal ground substance in the interstitium. Because Elmiron is a sulfated polyanion, we suggest that the myxomatous change may indicate accumulation of the test material, or some form of it, in the lamina propria.
Although the administration of other CADs has been associated with deposition of vacuolated storing cells in the muscular wall of the intestine (20) , Elmiron is unique in that the storage is associated with rectal injury. Because of the particular localization of lesions in the rectum, the likelihood is that, due to poor oral bioavailability, the compound is excreted almost unchanged from the gastro-intestinal tract and present in high concentration in the feces. The primary physiological function of the rectum is the reabsorption of water; as water is reabsorbed, the solubility of Elmiron may decrease, thereby causing it to fall out of solution, with eventual increased concentration, local irritation, and absorption. Interestingly, in ammation and ulceration of the rectum were described following a clinical trial in cancer patients treated with 180, 270, and 400 mg/m 2 P.O. t.i.d. of Elmiron (15) . The ulcers were time-and dose-dependent. Rectal ulcers were not noted in either IV or SC Elmiron trials. Pathogenesis of the ulceration was suggested to be due to the removal of sulfur from the mucosa by Elmiron. Normally, a high concentration of sulfur-containing side chains is required in the mucus secreted by the rectum to serve as an effective mucosal barrier. Another suggested mechanism is related to the binding of unabsorbed Elmiron to mucosal b -broblastic growth factor, depriving the local tissues of a potential protectant and/or repair stimulant (15) .
Following its passage through the mucosal barrier, Elmiron was deposited within local macrophages. Migration of these cells or distribution of the drug by the blood and lymphatics may explain the presence of vacuolated histiocytes in lymph nodes, spleen, liver, and lungs. As no other types of cells manifested cytoplasmic vacuolation, we propose that Elmiron or its metabolites primarily affect the activity of lysosomal enzymes in macrophages, perhaps due to a high concentration of the compound in these cells.
The renal tubular epithelial vacuolation observed in the high-dose rats and the hepatocytic vacuolation seen in both species treated with the higher doses were not considered indicative of lysosomal-storage disorder but, rather, a degenerative change. The presence of hepatic in ammation in the male rats treated with 500 and 1,000 mg/kg/day and the increased severity of in ammation in mice of both sexes treated with the 1,000 mg/kg/day were characterized by aggregation of histiocytes mixed with other in ammatory cells. As the histiocytes did not have vacuolated cytoplasm, the change in the liver was not considered to be of the same nature as that involving the in ltrated macrophages described in the rectum, lymph nodes, spleen, and lungs.
The increase in WBC and lymphocytic counts corresponded with the in ammation and ulceration of the rectum and liver.
In conclusion, the 90-day oral administration of Elmiron to rats and mice was associated with the accumulation of foamy macrophages in multiple organs. Histochemical investigation of the vacuolated histiocytes indicated the presence of neutral and acidic mucins and lipidic material in the vacuoles. Transmission electron microscopy showed these vacuoles to be lysosomes that exhibited a variety of contents. These ndings suggest that the compound was deposited in the rectal lamina propria, accumulated within macrophages, and was distributed either by these cells or as a free chemical via the lymphatics and blood to different organs.
